Expanding its presence in the diagnostics market, life sciences company Agilent Technologies Inc. will pay $2.2bn in cash to buy Dako AS (cancer testing) from private equity firm EQT Partners. (May)
A large part of Dako’s business is from the sale of immunohistochemistry (IHC) tests to pathology labs. The company also...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?